Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    16575727 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline
2 Completed A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Conditions: HIV Infections;   TB
Intervention: Biological: MVA 85A
3 Completed Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
Condition: TB
Intervention: Biological: MVA 85A
4 Completed Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
Condition: Tuberculosis
Intervention: Biological: MVA 85A
5 Completed The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A (TB vaccine);   Biological: MVA 85A

Indicates status has not been verified in more than two years